Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature

American Journal of Medical Genetics

Volumn 98, Issue 2, 2001, Pages 168-175

  Kozma, Chahira ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Anticonvulsants; Fetal valproate syndrome; Multiple congenital anomalies; Seizure disorders; Teratogen; Valproic acid

Indexed keywords

VALPROIC ACID;

ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; EMBRYOPATHY; GROWTH RETARDATION; HUMAN; LONG TERM CARE; LUNG DISEASE; MALE; MENTAL RETARDATION MALFORMATION SYNDROME; MUSCULOSKELETAL DISEASE; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SEIZURE; SIBLING; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ADULT; ANTICONVULSANTS; EPILEPSY; FACE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIMB DEFORMITIES, CONGENITAL; MALE; NEURAL TUBE DEFECTS; NUCLEAR FAMILY; PREGNANCY; PREGNANCY COMPLICATIONS; VALPROIC ACID;

EID: 0035863662     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O     Document Type: Article

References (62)

1. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation
2. The lower respiratory organs
3. Verification of the fetal valproate syndrome phenotype
4. Valproate-induced biochemical abnormalities in pregnancy corrected by vitamins: A case report
5. Valproic acid and fetal abnormality
6. Valproic acid and congenital malformations. A case report
7. Valproic acid and spina bifida
8. Omphalocele in a newborn baby exposed to sodium valproate in utero
9. Teratogenic potential of valproic acid
10. Teratogenic effect of vaIproic acid and diphenylhydantoin on mouse embryos in culture
11. Preaxial polydactyly in the fetal valproate syndrome
12. Letter to the editor: Fetal valproate syndrome
13. Congenital abnormalities in two sibs exposed to valproic acid in utero
14. Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs
15. Possible teratogenic effect of valproic acid
16. Fetal valproate syndrome. Syndrome of the month
17. Mini review: Developmental toxicity of valproic acid
18. Letter to the Editor. Teratogenicity of valproic acid
19. Consensus guidelines: Preconception counseling, management, and care of the pregnant woman with epilepsy
20. The fetal valproate syndrome
21. Valproic acid-induced spina bifida: A mouse model
22. Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics
23. Possible teratogenicity of valproic acid
24. Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice
25. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo
26. Fetal valproate embryopathy in twins: Genetic modification of the response to a teratogen
27. Aplasia cutis congenita of the scalp in an infant exposed to valproic acid in utero
28. Congenital malformations associated with maternal use of valproic acid
29. Role of HOX genes in human development
30. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid
31. Lung hypoplasia - A possible teratogenic effect of valproate
32. Sodium valproate and neural tube defects
33. Respecification of vertebral identities by retinoic acid
34. Isolated fetal bilateral radial ray reduction associated with valproic acid usage
35. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs
36. In utero exposure to valproate and neural tube defects
37. Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information
38. Prognosis in fetal valproate syndrome
39. Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model
40. Stage-dependent skeletal malformations induced by valproic acid in rat
41. Anomalous right pulmonary artery origins in association with the fetal valproate syndrome
42. Anticonvulsant activity and embryotoxicity of valproic acid
43. Valproic acid and its metabolites: Placental transfer, neonatal pharmacokinetics, transfer via mother's milk, and clinical status in neonates of epileptic mothers
44. Valproate and spina bifida
45. Fetal valproate syndrome with reduction deformity of limb
46. The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort
47. Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure
48. Teratogenesis of calcium valproate in rabbits
49. Maternal valproic acid and congenital neural tube defects
50. Valproate and birth defects
51. Fetal valproate phenotype is recognizable by mid pregnancy
52. Preaxial ray reduction defects as part of valproic acid embryofetopathy
53. Sodium valproate-induced cardiovascular abnormalities in the Jcl:ICR mouse fetus: Peak sensitivity of gestational day and dose-dependent effect
54. Sodium valproate and neural tube defects
55. Possible valproate teratogenicity
56. Malformation, withdrawal manifestations, and hypoglycemia after exposure to valproate in utero
57. Teratogenic effects of anticonvulsants
58. Proximal phocomelia and radial ray aplasia in fetal valproic syndrome
59. A male with fetal valproate syndrome and autism
60. Fetal valproate syndrome: Is there a recognizable phenotype?
61. Neurological care of pregnant women with epilepsy